Vanda Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Washington United States (2002)

Organization Overview

First Clinical Trial
2004
NCT00490945
First Marketed Drug
2009
iloperidone (fanapt)
First NDA Approval
2009
iloperidone (fanapt)
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Vanda Pharmaceuticals | Vanda Pharmaceuticals Inc | VANDA PHARMACEUTICALS INC | VANDA PHARMS INC